Coronavirus: Trump’s aggressive advocacy of malaria drug divides medical community
APRIL 7, 2020 12:41:32 PM
If hydroxychloroquine becomes an accepted treatment, several pharmaceutical companies stand to profit, including shareholders and senior executives with connections to the president.
.png)
No hay comentarios:
Publicar un comentario